CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Allogene Therapeutics
Baylor College of Medicine
Baylor College of Medicine
Stanford University
University of Pennsylvania
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
University of Maryland, Baltimore
Dana-Farber Cancer Institute
University Health Network, Toronto
University of Pennsylvania
City of Hope Medical Center
Baylor College of Medicine
New Approaches to Neuroblastoma Therapy Consortium
University Health Network, Toronto
Leap Therapeutics, Inc.
Gilead Sciences
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Celyad Oncology SA
Chinese PLA General Hospital
Therapeutic Advances in Childhood Leukemia Consortium
H. Lee Moffitt Cancer Center and Research Institute
University College, London
Shanghai Ming Ju Biotechnology Co., Ltd.
Second Affiliated Hospital, School of Medicine, Zhejiang University
GlaxoSmithKline
Cancer Research UK
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
University of Maryland, Baltimore
Guangzhou Institute of Respiratory Disease
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Peking University
University of California, San Francisco
Dana-Farber Cancer Institute
Baylor College of Medicine
University of Arkansas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins